ÂÜÀòÂÒÂ×

Danielle Rudolph is an experienced professional in the biotechnology and clinical research sectors, currently serving as the Director at ACCELERATED BIOSCIENCES CORP. since March 2022. With previous roles as a Clinical Operations Consultant at OrthogenRx and a multi-faceted leader at ACCELERATED BIOSCIENCES CORP., where Danielle was the Founder and COO, significant contributions include strategic planning, project management, and securing financing. Earlier experience includes directing clinical research at Surgical Research Solutions, liaising for national accounts at Jazz Pharmaceuticals and EUSA Pharma, and overseeing protocols at the Spine Institute at Saint John's Health Center. Danielle's robust medical science liaison background spans multiple oncology disciplines and extensive expertise in clinical trial management, regulatory compliance, and stakeholder engagement, complemented by a degree in Biological Sciences from the University of Delaware.